Overgaard J: Hypoxic radiosensitization: adored and ignored.
J Clin Oncol 2007, 25:4066–4074.
Denny WA: Hypoxia-activated prodrugs in cancer therapy: progress to the clinic.
Future Oncol 2010, 6:419–428.
Wilson WR, Hay MP: Targeting hypoxia in cancer therapy.
Nat Rev Cancer 2011, 11:393–410.
Meng F, Evans JW, Bhupathi D, Banica M, Lan L, Lorente G, Duan JX, Cai X, Mowday AM, Guise CP, Maroz A, Anderson RF, Patterson AV, Stachelek GC, Glazer PM, Matteucci MD, Hart CP: Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302.
Mol Cancer Ther 2012, 11:740–751.
Sun JD, Liu Q, Wang J, Ahluwalia D, Ferraro D, Wang Y, Duan JX, Ammons WS, Curd JG, Matteucci MD, Hart CP: Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer.
Clin Cancer Res 2012, 18:758–770.
Secomb TW, Hsu R, Ong ET, Gross JF, Dewhirst MW: Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors.
Acta Oncol 1995, 34:313–316.
Cairns RA, Papandreou I, Sutphin PD, Denko NC: Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy.
Proc Natl Acad Sci U S A 2007, 104:9445–9450.
Saito K, Matsumoto S, Devasahayam N, Subramanian S, Munasinghe JP, Morris HD, Lizak MJ, Ardenkjaer-Larsen JH, Mitchell JB, Krishna MC: Transient decrease in tumor oxygenation after intravenous administration of pyruvate.
Magn Reson Med 2012, 67:801–807.
Diers AR, Broniowska KA, Chang CF, Hogg N: Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition.
Biochem J 2012, 444:561–571.
Kauppinen RA, Nicholls DG: Synaptosomal bioenergetics. The role of glycolysis, pyruvate oxidation and responses to hypoglycaemia.
Eur J Biochem 1986, 158:159–165.
Korzeniewski B, Harper ME, Brand MD: Proportional activation coefficients during stimulation of oxidative phosphorylation by lactate and pyruvate or by vasopressin.
Biochim Biophys Acta 1995, 1229:315–322.
Schaffer WT, Olson MS: The regulation of pyruvate oxidation during membrane depolarization of rat brain synaptosomes.
Biochem J 1980, 192:741–751.
Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ, Vierra M: Pancreatic tumors show high levels of hypoxia.
Int J Radiat Oncol Biol Phys 2000, 48:919–922.
Chang Q, Jurisica I, Do T, Hedley DW: Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer.
Cancer Res 2011, 71:3110–3120.
Liu Q, Sun JD, Wang J, Ahluwalia D, Baker AF, Cranmer LD, Ferraro D, Wang Y, Duan JX, Ammons WS, Curd JG, Matteucci MD, Hart CP: TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules.
Cancer Chemother Pharmacol 2012, 69:1487–1498.
Borad MJ, Reddy S, Uronis H, Sigal DS, Cohn AL, Schelman WR, Stephenson J, Chiorean EG, Rosen PJ, Ulrich B, Dragovich T, Del Prete S, Rarick M, Eng C, Kroll S, Ryan D: Randomized phase II study of the efficacy and safety of gemcitabine + TH-302 (G+T) vs gemcitabine (G) alone in previously untreated patients with advanced pancreatic cancer.
Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research 2012:LB-121.
Institute of Laboratory Animal Resources (U.S.): Guide for the care and use of laboratory animals. 7th edition. Washington, D.C: National Academy Press; 1996.
Ibrahim-Hashim A, Wojtkowiak JW, de Lourdes Coelho Ribeiro M, Estrella V, Bailey KM, Cornnell HH, Gatenby RA, Gillies RJ: Free Base Lysine Increases Survival and Reduces Metastasis in Prostate Cancer Model.
J Cancer Sci Ther 2011, Suppl 1(4):JCST-S1-004.
Rejniak KA, Estrella V, Chen T, Cohen AS, Lloyd MC, Morse DL: The role of tumor tissue architecture in treatment penetration and efficacy: an integrative study.
Front Oncol 2013, 3:111.
Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC Jr, Raleigh JA: Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
Gynecol Oncol 1998, 71:270–277.
Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL: Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Cancer Res 2000, 60:7075–7083.
van der Heijden MS, Brody JR, Gallmeier E, Cunningham SC, Dezentje DA, Shen D, Hruban RH, Kern SE: Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
Am J Pathol 2004, 165:651–657.
Dutta P, Le A, Vander Jagt DL, Tsukamoto T, Martinez GV, Dang CV, Gillies RJ: Evaluation of LDH-A and glutaminase inhibition in vivo by hyperpolarized 13C-pyruvate magnetic resonance spectroscopy of tumors.
Cancer Res 2013, 73:4190–4195.
Arteel GE, Thurman RG, Raleigh JA: Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state.
Eur J Biochem 1998, 253:743–750.
Matsumoto S, Hyodo F, Subramanian S, Devasahayam N, Munasinghe J, Hyodo E, Gadisetti C, Cook JA, Mitchell JB, Krishna MC: Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice.
J Clin Invest 2008, 118:1965–1973.
Halestrap AP, Meredith D: The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.
Pflugers Arch 2004, 447:619–628.
Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P: Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review.
Front Pharmacol 2011, 2:49.
Koch CJ: Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5.
Methods Enzymol 2002, 352:3–31.
Epstein T, Xu L, Gillies RJ, Gatenby RA: Separation of metabolic supply and demand: aerobic glycolysis as a normal physiological response to fluctuating energetic demands in the membrane.
Cancer Metab 2014, 2:7.
Garcia-Gonzalo FR, Cruz C, Munoz P, Mazurek S, Eigenbrodt E, Ventura F, Bartrons R, Rosa JL: Interaction between HERC1 and M2-type pyruvate kinase.
FEBS Lett 2003, 539:78–84.
Cunningham J, Estrella V, Lloyd M, Gillies R, Frieden BR, Gatenby R: Intracellular electric field and pH optimize protein localization and movement.
PLoS One 2012, 7:e36894.
Cuisnier O, Serduc R, Lavieille JP, Longuet M, Reyt E, Riva C: Chronic hypoxia protects against gamma-irradiation-induced apoptosis by inducing bcl-2 up-regulation and inhibiting mitochondrial translocation and conformational change of bax protein.
Int J Oncol 2003, 23:1033–1041.
Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
Nature 1996, 379:88–91.